Division of Nephrology Recent Visiting Professors/Invited Speakers
Name Date Venue Title of Talk
  Top of Page 2004 1997 1998 1999 2000 2001 2002 2003 2004
Dr. Mitchell Rosner January 12, 2004 Medical Associates of Savannah Georgia Continuous Renal Replacement Therapies: Kinetic Modeling, Dosing and Outcomes
Dr. Thomas Hostetter March 1, 2004 National Institutes of Diabetes and Digestive and Kidney Disease The Role of Aldosterone in the Progression of Kidney Disease
Dr. Jeffrey Schelling April 12, 2004 Metro Health Medical Center, Case Western University NHE1 is a Cell Survival Protein
Dr. Terry Watnick April 26, 2004 Johns Hopkins School of Medicine The Role of DNA Diagnostics in ADPKD
  Top of Page 2003 1997 1998 1999 2000 2001 2002 2003 2004
Dr. Andrew Narva February 24, 2003 Indian Health Service Kidney Disease Program, Albuquerque, New Mexico The Spectrum of Kidney Disease in American Indians
Dr. Brian Pereira March 17, 2003 Tufts University School of Medicine Optimization of Care of Patients with Chronic Kidney Disease (CKD): The Key to Improved ESRD Outcomes
Dr. Didier Portilla May 5, 2003 University of Arkansas for Medical Science The Role of PPARa in Proximal Tubule Repair During Acute Renal Failure
Dr. John Sedor May 9, 2003 Case Western Reserve University WT1, The Podocyte and Glomerular Scarring
Dr. Thomas Coffman September 15, 2003 Duke University Medical Center Insights Into AT1 Receptor Functions From Gene Targeting
Dr. Mitchell Rosner September 22, 2003 Medical Associates of Savannah Georgia Mechanisms of Hypertension and Obesity
Dr. Richard Ward October 27, 2003 University of Louisville Effects of Uremia on Neutrophil Respiratory Burst Activity
Dr. Steven Fishbane December 8, 2003 Winthrop University Hospital Renal Protective Effects of Erythropoietin
  Top of Page 2002 1997 1998 1999 2000 2001 2002 2003 2004
Dr. Gerald Appel March 18, 2002 College of Physicians and Surgeons, New York Update of Focal Segmental Glomerulosclerosis
Dr. Robert Safirstein March 25, 2002 University of Arkansas The Stress Response and Renal Epithelial Injury - Therapeutic Implications
Dr. Donald Kohan April 29, 2002 University of Utah Medical Center Cell Specific Gene Targeting - New Approaches to Understanding Endothelin Biology in the Kidney
Dr. Gregory Germino May 24, 2002 Johns Hopkins University Molecular Pathogenesis of ADPKD: Emerging Concepts
Catherine Hedrick, PhD October 7, 2002 University of Virginia Endothelial Dysfunction in Atherosclerosis & Diabetes
Dr. Valerie Panzarino October 14, 2002 Medical University of South Carolina Growth Hormone in Renal Failure
Sven O.E. Ebbesson, PhD October 21, 2002 Institute of Marine Science - Fairbanks, Alaska Fatty Acid and Diabetes in Eskimos
Dr. Andre Kaplan November 18, 2002 University of Connecticut School of Medicine Update on Continuous Renal Replacement Therapies
  Top of Page 2001 1997 1998 1999 2000 2001 2002 2003 2004
Dr. Barry Kirschbaum January 8, 2001 Medical College of Virginia The Two Faces of Uric Acid
Dr. Jeffrey Fink January 26, 2001 University of Maryland VH and Anemia EPO Survival Data - Network J Data
Dr. Raymond C. Harris February 19, 2001 Vanderbilt University Potential Physiologic and Pathophysiologic - Roles of COX-2 in the Kidney
Dr. Barry Freedman March 15, 2001 Wake Forest University The Impact of Race and Genetics on Hypertensive Complications
Dr. John Raymond March 19, 2001 Charleston, SC  
Dr. Jill Lindberg March 26, 2001 Ochsner Clinic, New Orleans, LA The Healthy Start Experience
Dr. James C. M. Chan April 23, 2001 Medical College of Virginia Careers in Clinical Investigation
Dr. Susan DiGiovanni May 7, 2001 Medical College of VA Water Channels: Past, Present and Future
Dr. Robert G. Luke October 29, 2001 Hypertensive Nephrosclerosis Myth or Reality?
Dr. Lawrence Agodoa November 19, 2001 National Institutes of Health - Bethesda, MD Treatment of Hypertensive Nephrosclerosis Lessons Learned from the AASK Clinical Trial
  Top of Page 2000 1997 1998 1999 2000 2001 2002 2003 2004
Dr. Domenic Sica January 10, 2000 Medical College of Virginia Cardiovascular Profile and events in the African American Population
Dr. Kevin Meyers February 3, 2000 Children's Hospital of Philadelphia Molecular Analysis of Goodpasture's Autoantibodies
John Sargent, PhD February 14, 2000 Emeryville, California Medical Information: Creating Knowledge from Data
Dr. Andras Mogyorosi February 21, 2000 Medical College of Virginia ACE Inhibitors and Angiotensin Receptor Antagonists in Diabetic Nephropathy
Dr. Nicolas Guzman February 28, 2000 Georgetown University New Ideas on the Pathophysiology of Diabetic Kidney Disease
Dr. Anton Schoolwerth March 13, 2000 Medical College of Virginia Strategies for Managing Early Renal Failure
Dr. Hamid Rabb April 3, 2000 University of Minnesota Medical School Leukocytes and Leukocyte Adhesion Molecules in Renal Ischemia Reperfusion Injury
Dr. Sundaram Hariharan April 10, 2000 Medical College of Wisconsin Advances in Chronic Rejection
Dr. Michael Moore May 12, 2000 Wake Forest UniversitySchool of Medicine Resistant Hypertension
Dr. Michael Ganz May 15, 2000 Case Western Reserve University The Role of Shuttling Proteins and Diabetic Nephropathy
Dr. Thomas Hostetter May 26, 2000 University of Minnesota 9th Annual Virginia Retreat: Renin-Angiotensin-Aldosterone System in Progressive Renal Disease
Dr. Michael Flessner June 5, 2000 University of Rochester School of Medicine and Dentistry Limiting Factors in the Subperitoneal Dialysis System
Dr. Diana Karpman July 10, 2000 University of Lund, Lund, Sweden Experimental Models of HUS
Dr. Elizabeth Ripley December 4, 2000 Medical College of Virginia Hypertension: Past, Present and Future
  Top of Page 1999 1997 1998 1999 2000 2001 2002 2003 2004
Dr. Hanna Abboud February 1, 1999 University of Texas University Health System Platelet-Derived Growth Factor Receptor in Renal Development and Disease
Dr. Peter Morsing March 2, 1999 University of Lund, Lund, Sweden Mechanistic Differences of Various Angiotensin II AT1 Receptor Blockers in Cells, in Isolated Vessels of Different Origin and in Invivo Experiments
Dr. Norman Kaplan March 10, 1999 The University of Texas Southwestern Medical Center Hypertension
Dr. Henery Black April 26, 1999 St. Luke's Medical Center Clinical Trials in Hypertension - Is the Evidence as Solid as We Think?
Dr. Ronald J. Falk April 27, 1999 University of North Carolina Update on ANCA + Small Vessel Vasculitis
Dr. Alan Matsumoto May 3, 1999 University of Virginia Renovascular Hypertension and Insufficiency; Diagnosis & Therapy
Dr. Todd Gehr May 17, 1999 Medical College of Virginia What Nephrologists Need to Know About the New Anticoagulants
Dr. Jay Gillenwater September 10, 1999 University of Virginia Obstructive Uropathy
Dr. Wayne Border October 14,1999 University of Utah Role of TGFB in Renal Fibrosis
Dr. Morrell Avram October 18,1999 Long Island College Hospital Nutrition and Lipid in ESRD
Dr. Francisco Llach December 1, 1999 University of Medicine and Dentistry of New Jersey Hyperphosphatemia: Pathophysiologic Considerations and Therapeutic Management
  Top of Page 1998 1997 1998 1999 2000 2001 2002 2003 2004
Allan Collons, MD March 8, 1998 University of Minnesota Of Iron and Blood
Dr. D. Craig Brater March 23, 1998 Indiana UniversitySchool of Medicine Diuretic Resistance
Dr. Stuart Linas May 18, 1998 University of Colorado Renal Failure: Is the Endothelial Cell the Culprit?
Dr. Norman Siegel May 29, 1998 Yale University 1998 Va Retreat: Heat Shock Proteins in Renal Ischemia
Dr. Mark Ziedel July 20, 1998 University of Pittsburgh Renal Mechanism of Water Flow Across Biological Membranes
    1997 1997 1998 1999 2000 2001 2002 2003 2004
Dr. David Ellison February 3, 1997 Yale University The Molecular Basis of Diuretic Therapy: Lessons for Treating the Risistant Patient
Dr. John Sedor March 3, 1997 Case Western Reserve Mesangial Cell Activation and IL-1 Signaling: Laying the Foundation for Novel Therapies of Inflammatory Tissue Injury
Dr. George Bakris March 17, 1997 Rush St. Lukes Med. Ctr. Blood Pressure Control and the Progression of Nephropathy: Are All Drugs Created Equally?
Dr. Bruce Molitoris April 14, 1997 Indiana University Ischemia Induced Actin Cytoskeletal Alterations: Pathophysiology if Proximal Tubular Cell Injury
Dr. Jill Lindberg September 8, 1997 Ochsner Clinic Metabolic Bone Disease in End Stage Renal Disease - Poppourri
Dr. Jeff Sands October 7, 1997 Emory University Regulation of Kidney Urea Transporters
Dr. Luciano Barajas October 20, 1997 University of California The Juxtaglomerular Apparatus: Anatomical Basis of Current Functional Concepts
Dr. L. Darryl Quarles October 27, 1997 Duke University Medical Center Novel Regulators of Bone Formation: Role of Calcium Sensing Receptors and Pex
William Baricos, PhD December 9, 1997 Tulane University Medical School Role of Decreased Matrix Proteolysis in Glomerulosclerosis